SEC Form D · Amendment · filed December 30, 2016
Cue Biopharma, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Gary Schuman · CAMBRIDGE, MAExecRonald Seidel Iii · CAMBRIDGE, MAExecPeter Kiener · CAMBRIDGE, MADirectorSteven Mcknight · CAMBRIDGE, MADirectorBarry Simon · CAMBRIDGE, MADirectorRodolfo Chaparro · CAMBRIDGE, MAExecAmy Wang · CAMBRIDGE, MADirectorChristopher Marlett · CAMBRIDGE, MADirectorAnthony Digiandomenico · CAMBRIDGE, MADirectorDaniel Passeri · CAMBRIDGE, MAExec · DirectorCameron Gray · CAMBRIDGE, MADirectorMikhail Segal · New York, NYDirectorChristian Sugiarto · Hong Kong, IsraelExecDovey Wan · CUPERTINO, CADirectorJoel J. Schwartz · NEW YORK, NYExecMitchell Liu · CUPERTINO, CADirectorRon Fischer · New York, NYDirectorPaul Segal · New York, NYExecRidwan Budijono · Hong Kong, IsraelExec · DirectorLanham Napier · Austin, TXDirectorKenneth Herz · Austin, TXDirectorJames L. Curry · Austin, TXExec · DirectorAndrea R. Bruno · Maitland, FLDirectorTroy W. Eckard · Allen, TXDirectorPadraig Hoare · George Town, Cayman IslandsExec · DirectorFabio Rosati · Seattle, WADirectorKyla Fullenwider · Seattle, WADirectorElaine Mason · Seattle, WADirectorPeter E. Mogk · DETROIT, MIExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗